TY - JOUR
T1 - Concave microwell array-mediated three-dimensional tumor model for screening anticancer drug-loaded nanoparticles
AU - Kang, Ah Ran
AU - Seo, Hye In
AU - Chung, Bong Geun
AU - Lee, Sang Hoon
N1 - Funding Information:
This research was supported by BioNano Health-Guard Research Center funded by the Ministry of Science, ICT and Future Planning (MSIP) of Korea as Global Frontier Project (Grant number H-GUARD_2014M3A6B2060503 ), Republic of Korea and National Research Foundation of Korea (NRF) (No. 2013046403 ), Republic of Korea.
Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - We investigated the effect of anticancer drug-loaded functional polymeric nanoparticles on drug resistance of three-dimensional (3D) breast tumor spheroids. 3D tumor models were built using concave microwells with different diameters (300-700. μm) and nanoparticles were prepared using thermo-responsive poly(. N-isopropylacrylamide) (PNIPAM)-. co-acrylic acid (AA). Upon culturing with doxorubicin-loaded PNIPAM-. co-AA nanoparticles for 96. hours, the smallest tumor spheroids were extensively disrupted, resulting in a reduction in spheroid diameter. In contrast, the sizes of the largest tumor spheroids were not changed. Scanning electron microscopy revealed that the circular shape of 3D spheroids treated with doxorubicin-loaded PNIPAM-. co-AA nanoparticles had collapsed severely. Cell viability assays also demonstrated that the largest tumor spheroids cultured with doxorubicin-loaded PNIPAM-. co-AA nanoparticles were highly resistant to the anticancer drug. We confirmed that tight cell-cell contacts within largest tumor spheroids significantly improved the anticancer drug resistance. Therefore, this uniform-sized 3D breast tumor model could be a potentially powerful tool for anticancer drug screening applications. From the Clinical Editor: The battle against cancer is a big challenge. With new anti-cancer drugs being developed under the nanotechnology platform, there is a need to have a consistent and reliable testing system that mimics the in-vivo tumor scenario. The authors successfully designed a 3D tumor model using concave microwells to produce different tumor diameters. This will be of value for future drug screening.
AB - We investigated the effect of anticancer drug-loaded functional polymeric nanoparticles on drug resistance of three-dimensional (3D) breast tumor spheroids. 3D tumor models were built using concave microwells with different diameters (300-700. μm) and nanoparticles were prepared using thermo-responsive poly(. N-isopropylacrylamide) (PNIPAM)-. co-acrylic acid (AA). Upon culturing with doxorubicin-loaded PNIPAM-. co-AA nanoparticles for 96. hours, the smallest tumor spheroids were extensively disrupted, resulting in a reduction in spheroid diameter. In contrast, the sizes of the largest tumor spheroids were not changed. Scanning electron microscopy revealed that the circular shape of 3D spheroids treated with doxorubicin-loaded PNIPAM-. co-AA nanoparticles had collapsed severely. Cell viability assays also demonstrated that the largest tumor spheroids cultured with doxorubicin-loaded PNIPAM-. co-AA nanoparticles were highly resistant to the anticancer drug. We confirmed that tight cell-cell contacts within largest tumor spheroids significantly improved the anticancer drug resistance. Therefore, this uniform-sized 3D breast tumor model could be a potentially powerful tool for anticancer drug screening applications. From the Clinical Editor: The battle against cancer is a big challenge. With new anti-cancer drugs being developed under the nanotechnology platform, there is a need to have a consistent and reliable testing system that mimics the in-vivo tumor scenario. The authors successfully designed a 3D tumor model using concave microwells to produce different tumor diameters. This will be of value for future drug screening.
KW - Anticancer drug screening
KW - Concave microwell array
KW - Polymeric nanoparticle
KW - Three-dimensional tumor model
KW - Uniform-sized tumor
UR - http://www.scopus.com/inward/record.url?scp=84931026792&partnerID=8YFLogxK
U2 - 10.1016/j.nano.2015.02.009
DO - 10.1016/j.nano.2015.02.009
M3 - Article
C2 - 25752856
AN - SCOPUS:84931026792
SN - 1549-9634
VL - 11
SP - 1153
EP - 1161
JO - Nanomedicine: Nanotechnology, Biology, and Medicine
JF - Nanomedicine: Nanotechnology, Biology, and Medicine
IS - 5
ER -